OpenResearchAlpha

Neurology · 19 Nov 2026

Efficacy and Safety of 2 Rimegepant Dosing Regimens for the Prevention of Episodic Migraine

Peter J. Goadsbyh-index 86, Cristina Tassorelli, Robert J. Fountaine, Jeremias Antinew, Patrizia de Besi, Sergey Dubrovin, Kim Russell, Silvia Rosalia Kopf, Jim H. Hughes, Vittorio Loprinzo, Terence Fullertonh-index 0

0
Citations
no database records one yet
0
Citations in 2026
so far
86
Leading author's h-index
Peter J. Goadsby, in QAI's scholar index
19
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • OpenAlex0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

No abstract is available for this paper.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Peter J. Goadsby has the highest h-index among the authors (86).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (11)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (19)

What it cites, from open citation data, with Crossref's record of each.

Migraine
Nature Reviews Disease Primers · 2022
489
Efficacy and Safety of 2 Rimegepant Dosing Regimens for the Prevention of Episodic Migraine - QAI OpenResearch